News Announcement

Marksans Pharma: Unaudited Financial Results For The Quarter And Nine Months Ended December 31St 2019 And Limited Review Reports Thereon.

In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 kindly find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31st 2019 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. February 11 2020 along with Limited Review Reports thereon.

The meeting commenced at 12:00 p.m. and concluded at 12:50 p.m.

In this connection we hereby certify that the Auditors have given their reports on the Unaudited Financial Results for the quarter and nine months ended 31st December 2019 (both Standalone and Consolidated) with unmodified opinion.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.